{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:44:54Z","timestamp":1780087494709,"version":"3.54.0"},"reference-count":35,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,2]]},"DOI":"10.4269\/ajtmh.20-0185","type":"journal-article","created":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T07:01:01Z","timestamp":1591686061000},"page":"1088-1093","source":"Crossref","is-referenced-by-count":13,"title":["Efficacy and Safety of Pyronaridine\u2013Artesunate for the Treatment of Uncomplicated Plasmodium falciparum and Plasmodium vivax Malaria in Myanmar"],"prefix":"10.4269","volume":"103","author":[{"given":"Kay Thwe","family":"Han","sequence":"first","affiliation":[{"name":"Department of Medical Research, Ministry of Health and Sports, Yangon, Myanmar;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khin","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Medical Research (Pyin Oo Lwin Branch), Ministry of Health and Sports, Pyin Oo Lwin Township, Myanmar;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zay Yar","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Medical Research, Ministry of Health and Sports, Yangon, Myanmar;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moe Kyaw","family":"Myint","sequence":"additional","affiliation":[{"name":"Department of Medical Research (Pyin Oo Lwin Branch), Ministry of Health and Sports, Pyin Oo Lwin Township, Myanmar;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyin Hla","family":"Aye","sequence":"additional","affiliation":[{"name":"Department of Medical Research, Ministry of Health and Sports, Yangon, Myanmar;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aung","family":"Thi","sequence":"additional","affiliation":[{"name":"National Malaria Control Programme, Department of Public Health, Ministry of Health and Sports, Nay Pyi Taw, Myanmar;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Badri","family":"Thapa","sequence":"additional","affiliation":[{"name":"World Health Organization, Yangon, Myanmar;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Dorina","family":"Bustos","sequence":"additional","affiliation":[{"name":"World Health Organization, Bangkok, Thailand;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Borghini-Fuhrer","sequence":"additional","affiliation":[{"name":"Medicines for Malaria Venture, Geneva, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Ringwald","sequence":"additional","affiliation":[{"name":"World Health Organization, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Duparc","sequence":"additional","affiliation":[{"name":"Medicines for Malaria Venture, Geneva, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2795","reference":[{"key":"b1","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1056\/NEJMoa1513137","article-title":"A worldwide map of Plasmodium falciparum K13-propeller polymorphisms","volume":"374","author":"Menard","year":"2016","journal-title":"N Engl J Med"},{"key":"b2","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1126\/science.1260867","article-title":"Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates","volume":"347","author":"Straimer","year":"2015","journal-title":"Science"},{"key":"b3","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S1473-3099(18)30068-9","article-title":"Origins of the current outbreak of multidrug-resistant malaria in southeast Asia: a retrospective genetic study","volume":"18","author":"Amato","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"b4","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S1473-3099(19)30391-3","article-title":"Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study","volume":"19","author":"van der Pluijm","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"b5","first-page":"CD006404","article-title":"Pyronaridine-artesunate for treating uncomplicated Plasmodium falciparum malaria","volume":"1","author":"Pryce","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"b6","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/S0140-6736(18)30291-5","article-title":"Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b\/4 trial","volume":"391","year":"2018","journal-title":"Lancet"},{"key":"b7","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1473-3099(15)00318-7","article-title":"Safety and efficacy of re-treatments with pyronaridine-artesunate in African patients with malaria: a substudy of the WANECAM randomised trial","volume":"16","author":"Sagara","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"b8","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1475-2875-12-70","article-title":"Safety and efficacy of pyronaridine-artesunate in uncomplicated acute malaria: an integrated analysis of individual patient data from six randomized clinical trials","volume":"12","author":"Duparc","year":"2013","journal-title":"Malar J"},{"key":"b9","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1186\/1475-2875-11-364","article-title":"Pyronaridine-artesunate granules versus artemether-lumefantrine crushed tablets in children with Plasmodium falciparum malaria: a randomized controlled trial","volume":"11","author":"Kayentao","year":"2012","journal-title":"Malar J"},{"key":"b10","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1056\/NEJMoa1007125","article-title":"Pyronaridine-artesunate versus mefloquine plus artesunate for malaria","volume":"366","author":"Rueangweerayut","year":"2012","journal-title":"N Engl J Med"},{"key":"b11","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S0140-6736(10)60322-4","article-title":"Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial","volume":"375","author":"Tshefu","year":"2010","journal-title":"Lancet"},{"key":"b12","doi-asserted-by":"crossref","first-page":"e14501","DOI":"10.1371\/journal.pone.0014501","article-title":"Pyronaridine-artesunate versus chloroquine in patients with acute Plasmodium vivax malaria: a randomized, double-blind, non-inferiority trial","volume":"6","author":"Poravuth","year":"2011","journal-title":"PLoS One"},{"key":"b13","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1128\/AAC.00039-16","article-title":"Efficacy and safety of pyronaridine-artesunate for treatment of uncomplicated Plasmodium falciparum malaria in western Cambodia","volume":"60","author":"Leang","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"b14","doi-asserted-by":"crossref","first-page":"e01273-19","DOI":"10.1128\/AAC.01273-19","article-title":"Efficacy and safety of pyronaridine-artesunate plus single-dose primaquine for the treatment of malaria in western Cambodia","volume":"63","author":"Leang","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"b15","doi-asserted-by":"crossref","first-page":"e02242-18","DOI":"10.1128\/AAC.02242-18","article-title":"Efficacy and safety of pyronaridine-artesunate plus single-dose primaquine for treatment of uncomplicated Plasmodium falciparum malaria in eastern Cambodia","volume":"63","author":"Leang","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"b16","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1093\/cid\/ciz580","article-title":"Pyronaridine-artesunate efficacy and safety in uncomplicated Plasmodium falciparum malaria in areas of artemisinin-resistant falciparum in Viet Nam (2017\u20132018)","volume":"70","author":"Bui Quang","year":"2020","journal-title":"Clin Infect Dis"},{"key":"b17","volume-title":"World Malaria Report","year":"2019"},{"key":"b18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.12688\/wellcomeopenres.14761.1","article-title":"Entomological determinants of malaria transmission in Kayin state, eastern Myanmar: a 24-month longitudinal study in four villages","volume":"3","author":"Chaumeau","year":"2018","journal-title":"Wellcome Open Res"},{"key":"b19","doi-asserted-by":"crossref","first-page":"e0228190","DOI":"10.1371\/journal.pone.0228190","article-title":"Mass drug administrations with dihydroartemisinin-piperaquine and single low dose primaquine to eliminate Plasmodium falciparum have only a transient impact on Plasmodium vivax: findings from randomised controlled trials","volume":"15","author":"Phommasone","year":"2020","journal-title":"PLoS One"},{"key":"b20","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-3156.2007.01978.x","article-title":"Plasmodium vivax resistance to chloroquine in Dawei, southern Myanmar","volume":"13","author":"Guthmann","year":"2008","journal-title":"Trop Med Int Health"},{"key":"b21","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0035-9203(95)90556-1","article-title":"Development of resistance to chloroquine by Plasmodium vivax in Myanmar","volume":"89","author":"Marlar","year":"1995","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"b22","first-page":"101499","article-title":"Efficacy of directly-observed chloroquine-primaquine treatment for uncomplicated acute Plasmodium vivax malaria in northeast Myanmar: a prospective open-label efficacy trial","author":"Xu","year":"2019","journal-title":"Travel Med Infect Dis"},{"key":"b23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12936-017-1770-7","article-title":"Clinical and molecular surveillance of drug resistant vivax malaria in Myanmar (2009\u20132016)","volume":"16","author":"Nyunt","year":"2017","journal-title":"Malar J"},{"key":"b24","volume-title":"Template Protocol for Therapeutic Efficacy Studies","year":"2019"},{"key":"b25","first-page":"S1","article-title":"Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster","volume":"94","year":"2000","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"b26","volume-title":"Methods for Surveillance of Antimalarial Drug Efficacy","year":"2009"},{"key":"b27","volume-title":"Methods and Techniques for Clinical Trials on Antimalaria0l Drug Efficacy: genotyping to Identify Parasite Populations","year":"2008"},{"key":"b28","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature12876","article-title":"A molecular marker of artemisinin-resistant Plasmodium falciparum malaria","volume":"505","author":"Ariey","year":"2014","journal-title":"Nature"},{"key":"b29","doi-asserted-by":"crossref","first-page":"2019.006","DOI":"10.14411\/fp.2019.006","article-title":"K13 propeller domain mutations and pfmdr1 amplification in isolates of Plasmodium falciparum collected from Thai-Myanmar border area in 2006\u20132010","volume":"66","author":"Phompradit","year":"2019","journal-title":"Folia Parasitol (Praha)"},{"key":"b30","doi-asserted-by":"crossref","first-page":"E692","DOI":"10.3390\/genes10090692","article-title":"Genetic variations associated with drug resistance markers in asymptomatic Plasmodium falciparum infections in Myanmar","volume":"10","author":"Zhao","year":"2019","journal-title":"Genes (Basel)"},{"key":"b31","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1038\/s41467-019-10121-3","article-title":"Genomic structure and diversity of Plasmodium falciparum in southeast Asia reveal recent parasite migration patterns","volume":"10","author":"Shetty","year":"2019","journal-title":"Nat Commun"},{"key":"b32","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S1473-3099(15)70032-0","article-title":"Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker","volume":"15","author":"Tun","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"b33","doi-asserted-by":"crossref","first-page":"598","DOI":"10.4269\/ajtmh.19-0692","article-title":"Artemether-lumefantrine and dihydroartemisinin-piperaquine retain high efficacy for treatment of uncomplicated Plasmodium falciparum malaria in Myanmar","volume":"102","author":"Han","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"b34","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12936-017-1775-2","article-title":"Therapeutic efficacy and artemisinin resistance in northern Myanmar: evidence from in vivo and molecular marker studies","volume":"16","author":"Myint","year":"2017","journal-title":"Malar J"},{"key":"b35","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s12936-019-2924-6","article-title":"Increasing trends of malaria in a border area of the greater mekong subregion","volume":"18","author":"Geng","year":"2019","journal-title":"Malar J"}],"container-title":["The American Journal of Tropical Medicine and Hygiene"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T17:41:02Z","timestamp":1611769262000},"score":1,"resource":{"primary":{"URL":"https:\/\/ajtmh.org\/doi\/10.4269\/ajtmh.20-0185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,2]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9,2]]}},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.20-0185","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"value":"0002-9637","type":"print"},{"value":"1476-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,2]]}}}